These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30898480)

  • 1. Serum malondialdehyde-modified low-density lipoprotein levels on admission predict prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Amioka N; Miyoshi T; Otsuka H; Yamada D; Takaishi A; Ueeda M; Hirohata S; Ito H
    J Cardiol; 2019 Sep; 74(3):258-266. PubMed ID: 30898480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent.
    Ito T; Fujita H; Tani T; Ohte N
    Atherosclerosis; 2015 Apr; 239(2):311-7. PubMed ID: 25682029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus.
    Kotani K; Tashiro J; Yamazaki K; Nakamura Y; Miyazaki A; Bujo H; Saito Y; Kanno T; Maekawa M
    Clin Chim Acta; 2015 Oct; 450():145-50. PubMed ID: 26265234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Zhang J; He L
    BMC Cardiovasc Disord; 2021 Apr; 21(1):169. PubMed ID: 33845772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ma X; Sun Y; Cheng Y; Shen H; Gao F; Qi J; Yang L; Wang Z; Shi D; Liu Y; Liu X; Zhou Y
    Lipids Health Dis; 2020 Nov; 19(1):240. PubMed ID: 33198752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina.
    Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
    Circ J; 2020 Sep; 84(10):1837-1845. PubMed ID: 32863287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
    Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
    Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome.
    Wang C; Liao P; Tang C; Chen C; Zhang X
    Front Endocrinol (Lausanne); 2024; 15():1423227. PubMed ID: 39257901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
    Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
    Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
    J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD).
    Takamura TA; Tsuchiya T; Oda M; Watanabe M; Saito R; Sato-Ishida R; Akao H; Kawai Y; Kitayama M; Kajinami K
    Atherosclerosis; 2017 Aug; 263():192-197. PubMed ID: 28651186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive performance of aortic arch calcification for clinical outcomes in patients with acute coronary syndrome that undergo percutaneous coronary intervention: A prospective clinical study.
    Ma X; Dong L; Shao Q; Zhou Z; Tian J; Ma Y; Yang J; Lv S; Cheng Y; Shen H; Yang L; Wang Z; Zhou Y
    Medicine (Baltimore); 2019 Nov; 98(48):e18187. PubMed ID: 31770274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of malondialdehyde-modified low-density lipoprotein on clinical outcomes after fractional flow reserve-guided deferral of revascularization.
    Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
    Heart Vessels; 2021 May; 36(5):605-614. PubMed ID: 33219835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome.
    Kawabe M; Sato A; Hoshi T; Sakai S; Hiraya D; Watabe H; Kakefuda Y; Ishibashi M; Abe D; Takeyasu N; Aonuma K
    J Cardiol; 2016 Feb; 67(2):170-6. PubMed ID: 26228000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome].
    Zhang JH; Wang CH; Xu J; Ye L; Wang XC; Xu BL; Chen XH; Wu MZ; Cheng ZP; Xu Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):305-310. PubMed ID: 31060190
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
    Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
    J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome.
    Cheng L; Zhang L; Liu J; Li W; Bai X; Li R; Li B; Wang L; Zhou J; Wu Y; Yuan Z
    Dis Markers; 2020; 2020():7054596. PubMed ID: 32733619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patients.
    Wang Y; Yan BP; Nichol MB; Tomlinson B; Lee VWY
    Int J Cardiol; 2017 Dec; 249():18-24. PubMed ID: 29121725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.